nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0439	0.0726	CbGbCtD
Paliperidone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0397	0.0656	CbGbCtD
Paliperidone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0397	0.0656	CbGbCtD
Paliperidone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0343	0.0567	CbGbCtD
Paliperidone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0333	0.055	CbGbCtD
Paliperidone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0301	0.0497	CbGbCtD
Paliperidone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0301	0.0497	CbGbCtD
Paliperidone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0287	0.0473	CbGbCtD
Paliperidone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0269	0.0445	CbGbCtD
Paliperidone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0269	0.0445	CbGbCtD
Paliperidone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0244	0.0402	CbGbCtD
Paliperidone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0244	0.0402	CbGbCtD
Paliperidone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.021	0.0347	CbGbCtD
Paliperidone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0204	0.0337	CbGbCtD
Paliperidone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0185	0.0305	CbGbCtD
Paliperidone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0185	0.0305	CbGbCtD
Paliperidone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0182	0.0301	CbGbCtD
Paliperidone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0171	0.0283	CbGbCtD
Paliperidone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0171	0.0283	CbGbCtD
Paliperidone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0155	0.0256	CbGbCtD
Paliperidone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0155	0.0256	CbGbCtD
Paliperidone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0134	0.0221	CbGbCtD
Paliperidone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.013	0.0214	CbGbCtD
Paliperidone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0117	0.0194	CbGbCtD
Paliperidone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0117	0.0194	CbGbCtD
Paliperidone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0113	0.0186	CbGbCtD
Paliperidone—DRD1—nerve—acquired immunodeficiency syndrome	0.00303	0.0642	CbGeAlD
Paliperidone—DRD2—nerve—acquired immunodeficiency syndrome	0.00179	0.0379	CbGeAlD
Paliperidone—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.0015	0.0318	CbGeAlD
Paliperidone—HTR2A—nerve—acquired immunodeficiency syndrome	0.00118	0.025	CbGeAlD
Paliperidone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.0011	0.0233	CbGeAlD
Paliperidone—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0223	CbGeAlD
Paliperidone—DRD4—brain—acquired immunodeficiency syndrome	0.00104	0.0219	CbGeAlD
Paliperidone—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00101	0.0213	CbGeAlD
Paliperidone—DRD3—nervous system—acquired immunodeficiency syndrome	0.000953	0.0202	CbGeAlD
Paliperidone—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000917	0.0194	CbGeAlD
Paliperidone—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000894	0.0189	CbGeAlD
Paliperidone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000828	0.0175	CbGeAlD
Paliperidone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000814	0.0172	CbGeAlD
Paliperidone—DRD2—retina—acquired immunodeficiency syndrome	0.000742	0.0157	CbGeAlD
Paliperidone—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000732	0.0155	CbGeAlD
Paliperidone—DRD3—brain—acquired immunodeficiency syndrome	0.000728	0.0154	CbGeAlD
Paliperidone—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000705	0.0149	CbGeAlD
Paliperidone—DRD1—nervous system—acquired immunodeficiency syndrome	0.000682	0.0144	CbGeAlD
Paliperidone—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000657	0.0139	CbGeAlD
Paliperidone—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000656	0.0139	CbGeAlD
Paliperidone—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000629	0.0133	CbGeAlD
Paliperidone—ADRA1B—brain—acquired immunodeficiency syndrome	0.000559	0.0118	CbGeAlD
Paliperidone—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000553	0.0117	CbGeAlD
Paliperidone—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000538	0.0114	CbGeAlD
Paliperidone—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000535	0.0113	CbGeAlD
Paliperidone—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000532	0.0113	CbGeAlD
Paliperidone—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00053	0.0112	CbGeAlD
Paliperidone—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000529	0.0112	CbGeAlD
Paliperidone—DRD1—brain—acquired immunodeficiency syndrome	0.000522	0.011	CbGeAlD
Paliperidone—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000515	0.0109	CbGeAlD
Paliperidone—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00051	0.0108	CbGeAlD
Paliperidone—ADRA1A—blood—acquired immunodeficiency syndrome	0.000507	0.0107	CbGeAlD
Paliperidone—HTR2A—retina—acquired immunodeficiency syndrome	0.00049	0.0104	CbGeAlD
Paliperidone—ADRA2C—blood—acquired immunodeficiency syndrome	0.000483	0.0102	CbGeAlD
Paliperidone—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000465	0.00984	CbGeAlD
Paliperidone—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000447	0.00947	CbGeAlD
Paliperidone—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000446	0.00944	CbGeAlD
Paliperidone—DRD2—lung—acquired immunodeficiency syndrome	0.000435	0.00921	CbGeAlD
Paliperidone—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.00043	0.00909	CbGeAlD
Paliperidone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000424	0.00898	CbGeAlD
Paliperidone—ADRA2C—lung—acquired immunodeficiency syndrome	0.000423	0.00896	CbGeAlD
Paliperidone—HTR1B—brain—acquired immunodeficiency syndrome	0.000423	0.00894	CbGeAlD
Paliperidone—HRH1—digestive system—acquired immunodeficiency syndrome	0.000412	0.00871	CbGeAlD
Paliperidone—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000411	0.0087	CbGeAlD
Paliperidone—HTR1D—brain—acquired immunodeficiency syndrome	0.000409	0.00866	CbGeAlD
Paliperidone—HTR2C—brain—acquired immunodeficiency syndrome	0.000405	0.00858	CbGeAlD
Paliperidone—CYP3A5—blood—acquired immunodeficiency syndrome	0.000404	0.00855	CbGeAlD
Paliperidone—DRD2—nervous system—acquired immunodeficiency syndrome	0.000403	0.00853	CbGeAlD
Paliperidone—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000396	0.00838	CbGeAlD
Paliperidone—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000392	0.00829	CbGeAlD
Paliperidone—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000388	0.00821	CbGeAlD
Paliperidone—ADRA2A—blood—acquired immunodeficiency syndrome	0.000385	0.00815	CbGeAlD
Paliperidone—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000377	0.00799	CbGeAlD
Paliperidone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000374	0.00793	CbGeAlD
Paliperidone—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000371	0.00785	CbGeAlD
Paliperidone—HRH1—vagina—acquired immunodeficiency syndrome	0.000363	0.00769	CbGeAlD
Paliperidone—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000357	0.00756	CbGeAlD
Paliperidone—CYP3A5—lung—acquired immunodeficiency syndrome	0.000354	0.0075	CbGeAlD
Paliperidone—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000344	0.00728	CbGeAlD
Paliperidone—HRH1—lung—acquired immunodeficiency syndrome	0.000344	0.00728	CbGeAlD
Paliperidone—HTR1A—brain—acquired immunodeficiency syndrome	0.000341	0.00722	CbGeAlD
Paliperidone—ADRA2A—lung—acquired immunodeficiency syndrome	0.000338	0.00715	CbGeAlD
Paliperidone—HTR2A—blood—acquired immunodeficiency syndrome	0.000328	0.00693	CbGeAlD
Paliperidone—HRH1—nervous system—acquired immunodeficiency syndrome	0.000318	0.00674	CbGeAlD
Paliperidone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000318	0.00674	CbGeAlD
Paliperidone—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000316	0.00668	CbGeAlD
Paliperidone—ADRA1A—brain—acquired immunodeficiency syndrome	0.000314	0.00665	CbGeAlD
Paliperidone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000313	0.00663	CbGeAlD
Paliperidone—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000313	0.00662	CbGeAlD
Paliperidone—DRD2—brain—acquired immunodeficiency syndrome	0.000308	0.00652	CbGeAlD
Paliperidone—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000306	0.00649	CbGeAlD
Paliperidone—HTR2A—vagina—acquired immunodeficiency syndrome	0.000304	0.00643	CbGeAlD
Paliperidone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000303	0.00642	CbGeAlD
Paliperidone—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000301	0.00637	CbGeAlD
Paliperidone—ADRA2C—brain—acquired immunodeficiency syndrome	0.0003	0.00634	CbGeAlD
Paliperidone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000298	0.00632	CbGeAlD
Paliperidone—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000289	0.00613	CbGeAlD
Paliperidone—HTR2A—lung—acquired immunodeficiency syndrome	0.000287	0.00608	CbGeAlD
Paliperidone—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000266	0.00563	CbGeAlD
Paliperidone—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000256	0.00542	CbGeAlD
Paliperidone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000246	0.00521	CbGeAlD
Paliperidone—HRH1—brain—acquired immunodeficiency syndrome	0.000243	0.00515	CbGeAlD
Paliperidone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000242	0.00513	CbGeAlD
Paliperidone—ADRA2A—brain—acquired immunodeficiency syndrome	0.000239	0.00506	CbGeAlD
Paliperidone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000237	0.00502	CbGeAlD
Paliperidone—HRH1—lymph node—acquired immunodeficiency syndrome	0.000235	0.00498	CbGeAlD
Paliperidone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000233	0.00494	CbGeAlD
Paliperidone—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000231	0.00489	CbGeAlD
Paliperidone—HTR2A—brain—acquired immunodeficiency syndrome	0.000203	0.0043	CbGeAlD
Paliperidone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000185	0.00392	CbGeAlD
Paliperidone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000422	CcSEcCtD
Paliperidone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000422	CcSEcCtD
Paliperidone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000421	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000421	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000419	CcSEcCtD
Paliperidone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000121	0.000419	CcSEcCtD
Paliperidone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000121	0.000419	CcSEcCtD
Paliperidone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000419	CcSEcCtD
Paliperidone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000419	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000418	CcSEcCtD
Paliperidone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000418	CcSEcCtD
Paliperidone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000418	CcSEcCtD
Paliperidone—Pain—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000416	CcSEcCtD
Paliperidone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000416	CcSEcCtD
Paliperidone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000415	CcSEcCtD
Paliperidone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000415	CcSEcCtD
Paliperidone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000415	CcSEcCtD
Paliperidone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000414	CcSEcCtD
Paliperidone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000414	CcSEcCtD
Paliperidone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000413	CcSEcCtD
Paliperidone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000413	CcSEcCtD
Paliperidone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000119	0.000413	CcSEcCtD
Paliperidone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000412	CcSEcCtD
Paliperidone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000412	CcSEcCtD
Paliperidone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000119	0.000411	CcSEcCtD
Paliperidone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000119	0.000411	CcSEcCtD
Paliperidone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000411	CcSEcCtD
Paliperidone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.00041	CcSEcCtD
Paliperidone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00041	CcSEcCtD
Paliperidone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.00041	CcSEcCtD
Paliperidone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000409	CcSEcCtD
Paliperidone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000409	CcSEcCtD
Paliperidone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000408	CcSEcCtD
Paliperidone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000408	CcSEcCtD
Paliperidone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000408	CcSEcCtD
Paliperidone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000408	CcSEcCtD
Paliperidone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000406	CcSEcCtD
Paliperidone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000406	CcSEcCtD
Paliperidone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000405	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000405	CcSEcCtD
Paliperidone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000404	CcSEcCtD
Paliperidone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000403	CcSEcCtD
Paliperidone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000402	CcSEcCtD
Paliperidone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000116	0.0004	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.0004	CcSEcCtD
Paliperidone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.0004	CcSEcCtD
Paliperidone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000399	CcSEcCtD
Paliperidone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000399	CcSEcCtD
Paliperidone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000399	CcSEcCtD
Paliperidone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000115	0.000399	CcSEcCtD
Paliperidone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000398	CcSEcCtD
Paliperidone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000398	CcSEcCtD
Paliperidone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000115	0.000397	CcSEcCtD
Paliperidone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000397	CcSEcCtD
Paliperidone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000397	CcSEcCtD
Paliperidone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000396	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000396	CcSEcCtD
Paliperidone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000396	CcSEcCtD
Paliperidone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000114	0.000396	CcSEcCtD
Paliperidone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000396	CcSEcCtD
Paliperidone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000395	CcSEcCtD
Paliperidone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000394	CcSEcCtD
Paliperidone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000394	CcSEcCtD
Paliperidone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000393	CcSEcCtD
Paliperidone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000393	CcSEcCtD
Paliperidone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.000393	CcSEcCtD
Paliperidone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.000392	CcSEcCtD
Paliperidone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000392	CcSEcCtD
Paliperidone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000113	0.000392	CcSEcCtD
Paliperidone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000391	CcSEcCtD
Paliperidone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.00039	CcSEcCtD
Paliperidone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000113	0.00039	CcSEcCtD
Paliperidone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000389	CcSEcCtD
Paliperidone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000389	CcSEcCtD
Paliperidone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000389	CcSEcCtD
Paliperidone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000388	CcSEcCtD
Paliperidone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000388	CcSEcCtD
Paliperidone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000387	CcSEcCtD
Paliperidone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000387	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000386	CcSEcCtD
Paliperidone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000386	CcSEcCtD
Paliperidone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000385	CcSEcCtD
Paliperidone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000384	CcSEcCtD
Paliperidone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000384	CcSEcCtD
Paliperidone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000384	CcSEcCtD
Paliperidone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000383	CcSEcCtD
Paliperidone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.000383	CcSEcCtD
Paliperidone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000383	CcSEcCtD
Paliperidone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000111	0.000382	CcSEcCtD
Paliperidone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000382	CcSEcCtD
Paliperidone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.00038	CcSEcCtD
Paliperidone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.00038	CcSEcCtD
Paliperidone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.00038	CcSEcCtD
Paliperidone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00038	CcSEcCtD
Paliperidone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.00038	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000379	CcSEcCtD
Paliperidone—Rash—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000379	CcSEcCtD
Paliperidone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000379	CcSEcCtD
Paliperidone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000109	0.000379	CcSEcCtD
Paliperidone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000378	CcSEcCtD
Paliperidone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.000378	CcSEcCtD
Paliperidone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000109	0.000377	CcSEcCtD
Paliperidone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000109	0.000377	CcSEcCtD
Paliperidone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000376	CcSEcCtD
Paliperidone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000376	CcSEcCtD
Paliperidone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000376	CcSEcCtD
Paliperidone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000375	CcSEcCtD
Paliperidone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000108	0.000375	CcSEcCtD
Paliperidone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000373	CcSEcCtD
Paliperidone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000373	CcSEcCtD
Paliperidone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000373	CcSEcCtD
Paliperidone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000373	CcSEcCtD
Paliperidone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000373	CcSEcCtD
Paliperidone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000371	CcSEcCtD
Paliperidone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000371	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.00037	CcSEcCtD
Paliperidone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.00037	CcSEcCtD
Paliperidone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.00037	CcSEcCtD
Paliperidone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000367	CcSEcCtD
Paliperidone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000367	CcSEcCtD
Paliperidone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000366	CcSEcCtD
Paliperidone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000365	CcSEcCtD
Paliperidone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000365	CcSEcCtD
Paliperidone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000365	CcSEcCtD
Paliperidone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000365	CcSEcCtD
Paliperidone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000363	CcSEcCtD
Paliperidone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000363	CcSEcCtD
Paliperidone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000362	CcSEcCtD
Paliperidone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000362	CcSEcCtD
Paliperidone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000362	CcSEcCtD
Paliperidone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000361	CcSEcCtD
Paliperidone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000359	CcSEcCtD
Paliperidone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.000358	CcSEcCtD
Paliperidone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000358	CcSEcCtD
Paliperidone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000358	CcSEcCtD
Paliperidone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000357	CcSEcCtD
Paliperidone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000357	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000356	CcSEcCtD
Paliperidone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000356	CcSEcCtD
Paliperidone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000354	CcSEcCtD
Paliperidone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000353	CcSEcCtD
Paliperidone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000102	0.000352	CcSEcCtD
Paliperidone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000351	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000351	CcSEcCtD
Paliperidone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.00035	CcSEcCtD
Paliperidone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000349	CcSEcCtD
Paliperidone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000349	CcSEcCtD
Paliperidone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000349	CcSEcCtD
Paliperidone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000349	CcSEcCtD
Paliperidone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000348	CcSEcCtD
Paliperidone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Paliperidone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Paliperidone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Paliperidone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Paliperidone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.99e-05	0.000345	CcSEcCtD
Paliperidone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.95e-05	0.000344	CcSEcCtD
Paliperidone—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.94e-05	0.000344	CcSEcCtD
Paliperidone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.83e-05	0.00034	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.82e-05	0.00034	CcSEcCtD
Paliperidone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.78e-05	0.000338	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.76e-05	0.000338	CcSEcCtD
Paliperidone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.75e-05	0.000337	CcSEcCtD
Paliperidone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.75e-05	0.000337	CcSEcCtD
Paliperidone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.68e-05	0.000335	CcSEcCtD
Paliperidone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.68e-05	0.000335	CcSEcCtD
Paliperidone—Pain—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000334	CcSEcCtD
Paliperidone—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000334	CcSEcCtD
Paliperidone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.000333	CcSEcCtD
Paliperidone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.61e-05	0.000332	CcSEcCtD
Paliperidone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.6e-05	0.000332	CcSEcCtD
Paliperidone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.6e-05	0.000332	CcSEcCtD
Paliperidone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.59e-05	0.000332	CcSEcCtD
Paliperidone—Rash—Zidovudine—acquired immunodeficiency syndrome	9.52e-05	0.000329	CcSEcCtD
Paliperidone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.52e-05	0.000329	CcSEcCtD
Paliperidone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.52e-05	0.000329	CcSEcCtD
Paliperidone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000328	CcSEcCtD
Paliperidone—Headache—Zidovudine—acquired immunodeficiency syndrome	9.46e-05	0.000327	CcSEcCtD
Paliperidone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.39e-05	0.000325	CcSEcCtD
Paliperidone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.37e-05	0.000324	CcSEcCtD
Paliperidone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.36e-05	0.000324	CcSEcCtD
Paliperidone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.33e-05	0.000323	CcSEcCtD
Paliperidone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.31e-05	0.000322	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.31e-05	0.000322	CcSEcCtD
Paliperidone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.3e-05	0.000322	CcSEcCtD
Paliperidone—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.29e-05	0.000321	CcSEcCtD
Paliperidone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.28e-05	0.000321	CcSEcCtD
Paliperidone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.28e-05	0.000321	CcSEcCtD
Paliperidone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.24e-05	0.00032	CcSEcCtD
Paliperidone—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000319	CcSEcCtD
Paliperidone—Pain—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000319	CcSEcCtD
Paliperidone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.11e-05	0.000315	CcSEcCtD
Paliperidone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.08e-05	0.000314	CcSEcCtD
Paliperidone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.99e-05	0.000311	CcSEcCtD
Paliperidone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.98e-05	0.000311	CcSEcCtD
Paliperidone—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.97e-05	0.00031	CcSEcCtD
Paliperidone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.94e-05	0.000309	CcSEcCtD
Paliperidone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.94e-05	0.000309	CcSEcCtD
Paliperidone—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.93e-05	0.000309	CcSEcCtD
Paliperidone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.89e-05	0.000307	CcSEcCtD
Paliperidone—Rash—Indinavir—acquired immunodeficiency syndrome	8.86e-05	0.000306	CcSEcCtD
Paliperidone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.85e-05	0.000306	CcSEcCtD
Paliperidone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.82e-05	0.000305	CcSEcCtD
Paliperidone—Headache—Indinavir—acquired immunodeficiency syndrome	8.8e-05	0.000304	CcSEcCtD
Paliperidone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.78e-05	0.000304	CcSEcCtD
Paliperidone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.69e-05	0.000301	CcSEcCtD
Paliperidone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.65e-05	0.000299	CcSEcCtD
Paliperidone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000296	CcSEcCtD
Paliperidone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000295	CcSEcCtD
Paliperidone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000295	CcSEcCtD
Paliperidone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.44e-05	0.000292	CcSEcCtD
Paliperidone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.43e-05	0.000291	CcSEcCtD
Paliperidone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.4e-05	0.00029	CcSEcCtD
Paliperidone—Rash—Efavirenz—acquired immunodeficiency syndrome	8.37e-05	0.000289	CcSEcCtD
Paliperidone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.36e-05	0.000289	CcSEcCtD
Paliperidone—Nausea—Indinavir—acquired immunodeficiency syndrome	8.34e-05	0.000289	CcSEcCtD
Paliperidone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.33e-05	0.000288	CcSEcCtD
Paliperidone—Headache—Efavirenz—acquired immunodeficiency syndrome	8.32e-05	0.000288	CcSEcCtD
Paliperidone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.31e-05	0.000287	CcSEcCtD
Paliperidone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.11e-05	0.00028	CcSEcCtD
Paliperidone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.07e-05	0.000279	CcSEcCtD
Paliperidone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.04e-05	0.000278	CcSEcCtD
Paliperidone—Rash—Delavirdine—acquired immunodeficiency syndrome	8.01e-05	0.000277	CcSEcCtD
Paliperidone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8e-05	0.000277	CcSEcCtD
Paliperidone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8e-05	0.000277	CcSEcCtD
Paliperidone—Headache—Delavirdine—acquired immunodeficiency syndrome	7.96e-05	0.000275	CcSEcCtD
Paliperidone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.94e-05	0.000275	CcSEcCtD
Paliperidone—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.88e-05	0.000273	CcSEcCtD
Paliperidone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.77e-05	0.000269	CcSEcCtD
Paliperidone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.74e-05	0.000268	CcSEcCtD
Paliperidone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.73e-05	0.000267	CcSEcCtD
Paliperidone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.63e-05	0.000264	CcSEcCtD
Paliperidone—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.54e-05	0.000261	CcSEcCtD
Paliperidone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.47e-05	0.000259	CcSEcCtD
Paliperidone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.47e-05	0.000258	CcSEcCtD
Paliperidone—Rash—Ritonavir—acquired immunodeficiency syndrome	7.4e-05	0.000256	CcSEcCtD
Paliperidone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.4e-05	0.000256	CcSEcCtD
Paliperidone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.38e-05	0.000255	CcSEcCtD
Paliperidone—Headache—Ritonavir—acquired immunodeficiency syndrome	7.36e-05	0.000254	CcSEcCtD
Paliperidone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.19e-05	0.000249	CcSEcCtD
Paliperidone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.13e-05	0.000247	CcSEcCtD
Paliperidone—Rash—Saquinavir—acquired immunodeficiency syndrome	7.13e-05	0.000247	CcSEcCtD
Paliperidone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.12e-05	0.000246	CcSEcCtD
Paliperidone—Headache—Saquinavir—acquired immunodeficiency syndrome	7.08e-05	0.000245	CcSEcCtD
Paliperidone—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.98e-05	0.000241	CcSEcCtD
Paliperidone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.86e-05	0.000237	CcSEcCtD
Paliperidone—Rash—Lamivudine—acquired immunodeficiency syndrome	6.8e-05	0.000235	CcSEcCtD
Paliperidone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.79e-05	0.000235	CcSEcCtD
Paliperidone—Headache—Lamivudine—acquired immunodeficiency syndrome	6.76e-05	0.000234	CcSEcCtD
Paliperidone—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.71e-05	0.000232	CcSEcCtD
Paliperidone—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.41e-05	0.000222	CcSEcCtD
Paliperidone—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.65e-05	0.000455	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.64e-05	0.000454	CbGpPWpGaD
Paliperidone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.62e-05	0.000449	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.62e-05	0.000449	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.61e-05	0.000448	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.61e-05	0.000448	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.61e-05	0.000448	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.61e-05	0.000447	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.59e-05	0.000445	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.59e-05	0.000445	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.58e-05	0.000442	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.57e-05	0.000442	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.57e-05	0.000441	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.57e-05	0.000441	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.57e-05	0.000441	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.56e-05	0.000439	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.54e-05	0.000436	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.54e-05	0.000435	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.54e-05	0.000435	CbGpPWpGaD
Paliperidone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.51e-05	0.00043	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.5e-05	0.000428	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.5e-05	0.000428	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.49e-05	0.000427	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.48e-05	0.000425	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.47e-05	0.000424	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.46e-05	0.000422	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.45e-05	0.000421	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.44e-05	0.000419	CbGpPWpGaD
Paliperidone—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.44e-05	0.000418	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.41e-05	0.000413	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.41e-05	0.000413	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.39e-05	0.00041	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.39e-05	0.00041	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.37e-05	0.000407	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.37e-05	0.000407	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.37e-05	0.000407	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.37e-05	0.000406	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.36e-05	0.000405	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.36e-05	0.000405	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.36e-05	0.000404	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.35e-05	0.000404	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	2.34e-05	0.000401	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.34e-05	0.000401	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.33e-05	0.0004	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.33e-05	0.000399	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.32e-05	0.000399	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.32e-05	0.000398	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.28e-05	0.000392	CbGpPWpGaD
Paliperidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.27e-05	0.00039	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.27e-05	0.00039	CbGpPWpGaD
Paliperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.27e-05	0.000389	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.26e-05	0.000388	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.25e-05	0.000386	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.25e-05	0.000386	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.24e-05	0.000385	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.23e-05	0.000383	CbGpPWpGaD
Paliperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.23e-05	0.000382	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.22e-05	0.000381	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.22e-05	0.000381	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.2e-05	0.000377	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.19e-05	0.000376	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.19e-05	0.000375	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	2.19e-05	0.000375	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.000372	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.000372	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.17e-05	0.000372	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.17e-05	0.000371	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.16e-05	0.00037	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.15e-05	0.000369	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.15e-05	0.000369	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.15e-05	0.000368	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.14e-05	0.000366	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.13e-05	0.000366	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.13e-05	0.000365	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.13e-05	0.000365	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.12e-05	0.000364	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.12e-05	0.000363	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.11e-05	0.000363	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.11e-05	0.000361	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.09e-05	0.000358	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.07e-05	0.000356	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.06e-05	0.000353	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.05e-05	0.000351	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2e-05	0.000344	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2e-05	0.000344	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2e-05	0.000342	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.99e-05	0.000341	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.97e-05	0.000338	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.97e-05	0.000338	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.96e-05	0.000337	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.96e-05	0.000336	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.96e-05	0.000336	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.96e-05	0.000336	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.94e-05	0.000333	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.94e-05	0.000333	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.94e-05	0.000332	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.93e-05	0.000332	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.93e-05	0.000332	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.93e-05	0.000332	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.93e-05	0.000331	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.93e-05	0.000331	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.92e-05	0.00033	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.92e-05	0.00033	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.92e-05	0.00033	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.91e-05	0.000328	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.9e-05	0.000326	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.9e-05	0.000326	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.9e-05	0.000326	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.87e-05	0.000321	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.87e-05	0.000321	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.87e-05	0.000321	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.87e-05	0.000321	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.84e-05	0.000316	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.84e-05	0.000316	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.84e-05	0.000316	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.84e-05	0.000316	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.81e-05	0.00031	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.79e-05	0.000307	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.78e-05	0.000305	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.000305	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.78e-05	0.000304	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.77e-05	0.000304	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.76e-05	0.000302	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.74e-05	0.000298	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.74e-05	0.000298	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000298	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.71e-05	0.000294	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.71e-05	0.000293	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.7e-05	0.000292	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.7e-05	0.000291	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.7e-05	0.000291	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.69e-05	0.00029	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.68e-05	0.000289	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000287	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.67e-05	0.000287	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.67e-05	0.000287	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.67e-05	0.000286	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.67e-05	0.000286	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.66e-05	0.000285	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.66e-05	0.000285	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.64e-05	0.000281	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.64e-05	0.000281	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.64e-05	0.000281	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.62e-05	0.000277	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.54e-05	0.000264	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.52e-05	0.000261	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.52e-05	0.000261	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.52e-05	0.000261	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.52e-05	0.000261	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.51e-05	0.000259	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.5e-05	0.000257	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.49e-05	0.000255	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.48e-05	0.000254	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.47e-05	0.000252	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.46e-05	0.000251	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000249	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.44e-05	0.000247	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000245	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000244	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.42e-05	0.000244	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.00024	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.4e-05	0.00024	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000237	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.38e-05	0.000237	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.37e-05	0.000235	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.36e-05	0.000233	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.34e-05	0.00023	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000227	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.32e-05	0.000226	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000222	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.29e-05	0.000222	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.29e-05	0.000221	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.00022	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.27e-05	0.000218	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.27e-05	0.000218	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.27e-05	0.000218	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.26e-05	0.000216	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000215	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000215	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.000215	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.25e-05	0.000214	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000213	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000212	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000212	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000211	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.00021	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000207	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.16e-05	0.0002	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.16e-05	0.000198	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000196	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.14e-05	0.000196	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.14e-05	0.000195	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000195	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000192	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000192	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000188	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.09e-05	0.000187	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.04e-05	0.000179	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000176	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.02e-05	0.000175	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000175	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1e-05	0.000172	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.89e-06	0.00017	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.84e-06	0.000169	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.9e-06	0.000153	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	8.88e-06	0.000152	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.86e-06	0.000152	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.79e-06	0.000151	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.74e-06	0.00015	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	8.13e-06	0.00014	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.93e-06	0.000136	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.89e-06	0.000135	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.66e-06	0.000131	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.62e-06	0.000131	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.62e-06	0.000131	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.58e-06	0.00013	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.41e-06	0.000127	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.37e-06	0.000126	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.29e-06	0.000125	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.26e-06	0.000124	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.72e-06	0.000115	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.69e-06	0.000115	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.61e-06	0.000113	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.6e-06	0.000113	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.58e-06	0.000113	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.57e-06	0.000113	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.48e-06	0.000111	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.44e-06	0.000111	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.03e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.02e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.99e-06	0.000103	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.91e-06	0.000101	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.81e-06	9.97e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	5.78e-06	9.92e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.23e-06	8.98e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.16e-06	8.86e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.66e-06	8e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.5e-06	7.72e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.48e-06	7.68e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.35e-06	7.47e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.29e-06	7.35e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.95e-06	6.78e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.89e-06	6.67e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.88e-06	6.65e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.81e-06	6.53e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	3.78e-06	6.49e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.54e-06	6.07e-05	CbGpPWpGaD
